There are 3397 resources available
Biomarker-selected therapy: Progress or delusion?
Presenter: Paul Baas
Session: Open questions in the management of mesothelioma
Resources:
Slides
Webcast
Drug sensitivity testing in blood cancer
Presenter: Thorsten Zenz
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast
India’s approach to advance access to cancer medicines
Presenter: Manju Sengar
Session: Making essential cancer drugs affordable
Resources:
Slides
Webcast
Peptide-based cancer vaccines
Presenter: Juliane Walz
Session: New targets on the horizon
Resources:
Slides
Webcast
New approaches in cancer vaccines
Presenter: Sjoerd van der Burg
Session: Advancing strategies for cancer immunotherapy
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer
Resources:
Slides
Webcast
Preoperative or postoperative radiation for mesothelioma
Presenter: Kenneth Rosenzweig
Session: Open questions in the management of mesothelioma
Resources:
Slides
Webcast
Mutant specific inhibitors
Presenter: Alexander Drilon
Session: New targets on the horizon
Resources:
Slides
Webcast
How novel profiling methods impact trial design
Presenter: Richard Schlenk
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Making essential cancer drugs affordable
Resources:
Slides
Webcast